Jun 01, 2022 / 03:00PM GMT
Aaron Gal - Sanford C. Bernstein & Co., LLC., Research Division - Senior Research Analyst
Hi, everybody. So let's go ahead and start. Today with us we have Rob, Jeff and Neil from left to right. Rob is the CFO. Jeff's run the commercial operation, and Neil runs the development of AbbVie. The CEO, Richard Gonzalez, was unable to join us today. He's a little bit under the weather and we all wish him a speedy recovery.
So in a way, we're kind of fortunate the management team of AbbVie is giving us an opportunity to engage with the rest of the C officer suite that we typically don't engage with or typically not here on quarterly calls and here we are. So we have a chance to do this and ask them some interesting questions. I'm going to try to reserve the last 5 minutes to questions. Just if you want to ask questions, raise your heads -- your hands, and we'll ask you then.
So with that, let's go ahead and start. I thought we'll lead some specifics around development, commercial and the overall picture of the company and then see where it takes us.
Abbvie Inc at Sanford C Bernstein Strategic Decisions Conference Transcript
Jun 01, 2022
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers